Central administration of palmitoylethanolamide lessens hyperalgesia in mice by using inhibition of NF‐κB nuclear signalling in dorsal root ganglia. Eur J Pharmacol All a few reports are in step with current literature on PEA’s considerable therapeutic index, which makes it an interesting prospect for the very first line treatment https://caidenifzul.blazingblog.com/30748199/palmitoylethanolamide-an-overview